Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pyruvate dehydrogenase phosphatase catalytic subunit 1 (PDP1) is a mitochondrial enzyme of the protein phosphatase 2C family that catalyzes the Mg2+/Mn2+-dependent dephosphorylation and activation of the E1 subunit of the pyruvate dehydrogenase complex (PDC). This reactivates the complex, facilitating the conversion of pyruvate to acetyl-CoA—a critical link between glycolysis and the tricarboxylic acid cycle, essential for cellular energy production. PDP1 activity is regulated by calcium and is predominantly expressed in skeletal muscle, with mutations leading to rare, autosomal recessive disorders characterized by lactic acidosis, developmental delay, and neurological symptoms. PDP1 is a validated enzyme target, but no selective pharmacological modulators are yet in approved therapeutic use[1][2][3][7].
Enhancement or inhibition of PDP1 would regulate the dephosphorylation and activation status of the pyruvate dehydrogenase complex, modulating cellular acetyl-CoA production and mitochondrial energy output[2][3][7]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pyruvate dehydrogenase phosphatase catalytic subunit 1 (PDP1).